We confirmed that SCD retains significant enzymatic activity even in really hypoxic conditions—a result that should motivate SCD inhibitor therapeutics in other reliable tumors. Besides delaying tumor expansion, the inhibitor had an unforeseen helpful effect on tumor vasculature, secondary to its effect on tumor cells. GBM can be a hugely vascula